1
|
Kiracı M, Bilgin E, Duran E, Farisoğulları B, Bölek EC, Yardımcı GK, Ozsoy Z, Ayan G, Uzun GS, Akbaba TH, Balci-Peynircioglu B, Karadag O, Akdogan A, Bilgen SA, Kiraz S, Ertenli AI, Kalyoncu U, Kılıç L. Comparison of demographic, clinic and radiological features of patients with axial spondyloarthritis accompanying familial Mediterranean fever to patients with each condition alone. Scand J Rheumatol 2023; 52:530-538. [PMID: 36503416 DOI: 10.1080/03009742.2022.2143621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Accepted: 11/01/2022] [Indexed: 12/14/2022]
Abstract
OBJECTIVE To compare the demographic, clinical, and radiological features of patients with axial spondyloarthritis (axSpA) accompanying familial Mediterranean fever (FMF) to patients with each condition alone. METHOD Hacettepe University Hospital database was screened regarding ICD-10 codes for FMF (E85.0) and axSpA (M45). The diagnosis of FMF was confirmed by Tel-Hashomer criteria, and axSpA by the presence of sacroiliitis according to the modified New York criteria or active sacroiliitis on magnetic resonance imaging. As control groups, 136 gender-matched, consequent FMF patients without axSpA and 102 consequent axSpA patients without FMF previously treated with any biological agents were included in the analysis. RESULTS In patients with FMF + axSpA compared to the axSpA group, age at axSpA symptom onset and age at diagnosis were lower [median with interquartile range (IQR): 21 (17-30) vs 27 (21-37), p < 0.001; 23 (21-38) vs 32 (24-43) years, p = 0.001], moderate to severe hip disease and total hip replacement were more prevalent (23.4% vs 4.7%, p < 0.001; 11.2% vs 2.8%, p = 0.016). In patients with FMF + axSpA compared to the FMF group, age at FMF symptom onset and age at diagnosis were higher [13 (6-30) vs 11 (5-18), p = 0.057; 23 (13-33) vs 18 (10-31) years, p = 0.033] and amyloidosis was more prevalent (6.6% vs 2.2%, p = 0.076). Although the M694V variant (in one or two alleles) was more prevalent in the FMF + axSpA group, the difference was not statistically significant. CONCLUSION In patients with FMF + axSpA, the age of onset of axSpA was significantly earlier, moderate to severe hip involvement and amyloidosis were more common than in patients with each condition alone.
Collapse
Affiliation(s)
- M Kiracı
- Department of Internal Medicine, Hacettepe University, Ankara, Turkey
| | - E Bilgin
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - E Duran
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - B Farisoğulları
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - E C Bölek
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - G K Yardımcı
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - Z Ozsoy
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - G Ayan
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - G S Uzun
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - T H Akbaba
- Department of Medical Biology, Hacettepe University, Ankara, Turkey
| | | | - O Karadag
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - A Akdogan
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - S A Bilgen
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - S Kiraz
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - A I Ertenli
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - U Kalyoncu
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| | - L Kılıç
- Department of Internal Medicine, Hacettepe University, Ankara, Turkey
- Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey
| |
Collapse
|
2
|
Batu ED, Erden A, Seyhoğlu E, Kilic L, Büyükasık Y, Karadag O, Bilginer Y, Bilgen SA, Akdogan A, Kiraz S, Ertenli AI, Özen S, Kalyoncu U. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases. Scand J Rheumatol 2016; 46:44-48. [PMID: 27359073 DOI: 10.3109/03009742.2016.1167951] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
OBJECTIVES Reactive haemophagocytic syndrome (RHS) is a hyperinflammatory disorder often occurring in the background of several disorders such as infections, malignancies, and rheumatic diseases. Recently, a score known as the HScore was developed for the diagnosis of RHS. In the original study, most of the patients had underlying haematological malignancy or infection and the best cut-off value for the HScore was 169 (sensitivity 93%; specificity 86%). In this study we aimed to analyse the performance of the HScore in rheumatic disease-related RHS. METHOD The patients with rheumatic disorders evaluated in the Departments of Rheumatology and Paediatric Rheumatology at Hacettepe University, Ankara, Turkey between 2002 and 2014 were reviewed retrospectively. The first group (n = 30) consisted of patients with RHS; the control group (n = 64) included patients with active rheumatic diseases without RHS. RESULTS In the RHS group, 14 (46.7%) had adult-onset Still's disease (AOSD), 10 (33.3%) systemic juvenile idiopathic arthritis (SJIA), and six (20%) systemic lupus erythematosus (SLE). The control group (n = 64) consisted of 32 (50%) AOSD, 13 (20.3%) SJIA, and 19 (29.7%) SLE patients. Applying the HScore to the RHS patients, the best cut-off value was 190.5 with a sensitivity of 96.7% and specificity of 98.4%. When we excluded the patients from the control group who had not had bone marrow aspiration (n = 23), the same cut-off (190.5) performed best (sensitivity 96.7%; specificity 97.6%). Applying the 2004 haemophagocytic lymphohistiocytosis (HLH-2004) criteria gave a sensitivity of 56.6% and a specificity of 100% in the whole study group. CONCLUSIONS In our study, a cut-off value for the HScore different from the original study performed better. Further studies are warranted to determine optimum cut-off values in different studies.
Collapse
Affiliation(s)
- E D Batu
- a Department of Paediatrics, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - A Erden
- b Department of Internal Medicine, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - E Seyhoğlu
- c Department of Internal Medicine , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - L Kilic
- b Department of Internal Medicine, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - Y Büyükasık
- d Department of Internal Medicine, Division of Haematology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - O Karadag
- b Department of Internal Medicine, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - Y Bilginer
- a Department of Paediatrics, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - S A Bilgen
- b Department of Internal Medicine, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - A Akdogan
- b Department of Internal Medicine, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - S Kiraz
- b Department of Internal Medicine, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - A I Ertenli
- b Department of Internal Medicine, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - S Özen
- a Department of Paediatrics, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| | - U Kalyoncu
- b Department of Internal Medicine, Division of Rheumatology , Hacettepe University Faculty of Medicine , Ankara , Turkey
| |
Collapse
|
3
|
Bilgen SA, Kalyoncu U, Kilic L, Karadag O, Canpolat U, Aytemir K, Kiraz S, Akdogan A, Kaya B, Ertenli I. AB0589 Subclinical atherosclerosis found both in psoriatic arthritis and rheumatoid arthritis. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.2911] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
4
|
Karadag O, Kilic L, Erbil AA, Yılmaz N, Akdogan A, Kalyoncu U, Bilgen SA, Kiraz S. AB0357 Pregnancy outcomes of rheumatic patients with pre/peri gestational leflunomide exposure. Ann Rheum Dis 2014. [DOI: 10.1136/annrheumdis-2013-eular.2679] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
5
|
Akdogan A, Kilic L, Akman U, Dogan I, Karadag O, Bilgen SA, Buyukasik Y, Kiraz S, Ertenli I. Aspirin resistance in systemic lupus erythematosus. A pilot study. Lupus 2013; 22:835-8. [DOI: 10.1177/0961203313493487] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Systemic lupus erythematosus (SLE) patients are at increased risk of thrombosis and cardiovascular diseases. Aspirin is an effective treatment option for these patients. The aim of this study was to investigate the presence of aspirin resistance in SLE patients. We studied aspirin resistance in 33 SLE patients and nine healthy controls by using a Multiplate® impedance aggregometer (Dynabyte GmbH, Munich, Germany). Twenty-six SLE patients were on regular aspirin treatment. Aspirin resistance was found in five (19.2%) out of 26 patients who were on aspirin treatment. When the tests were repeated by adding acetylsalicylic acid in the medium, all of these patients became responsive to the aspirin. SLE disease activity, body mass index, smoking status, and the presence of anticardiolipin antibodies or positive lupus anticoagulant test results were no different in patients with or without aspirin resistance. ( p > 0.05 for all). Our results suggest that there may be a considerable number of SLE patients with aspirin resistance.
Collapse
Affiliation(s)
- A Akdogan
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| | - L Kilic
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| | - U Akman
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| | - I Dogan
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| | - O Karadag
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| | - SA Bilgen
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| | - Y Buyukasik
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| | - S Kiraz
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| | - I Ertenli
- Division of Rheumatology, Department of Internal Medicine, Hacettepe University Hospital, Turkey and 2Division of Hematology, Department of Internal Medicine, Hacettepe University Hospital, Turkey
| |
Collapse
|
6
|
Kalyoncu U, Kilic L, Karadag O, Bilgen SA, Kiraz S, Akdogan A, Ertenli I. THU0200 Comparison of Quantiferon-TB Test and TST in Routine Practice During Anti-TNF Treatment. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
7
|
Er E, Akdogan A, Kilic L, Canpolat U, Kaya B, Karadag O, Kalyoncu U, Bilgen SA, Kiraz S, Hayran M, Ertenli I. AB0430 What is the role of ambulatory blood pressure monitoring in sle? Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2752] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
8
|
Karadag O, Kilic L, Erbil AA, Aydın NN, Tuncer O, Akdogan A, Bilgen SA, Sener B, Ertenli I, Kiraz S. AB0424 Has the role of ana in differential diagnosis of connective tissue diseases been changed after technological developments? Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|